| Lauren Rigg, MD | |
|
5521 W Lincoln Hwy Ste 100, Crown Point, IN 46307-1098 | |
| (219) 756-6100 | |
| Not Available |
| Full Name | Lauren Rigg |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 7 Years |
| Location | 5521 W Lincoln Hwy Ste 100, Crown Point, Indiana |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427583962 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 01087133A (Indiana) | Primary |
| 207K00000X | Allergy & Immunology | 036.152445 (Illinois) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Asthma Care P.c. | 5698779080 | 7 |
News Archive
Open Monoclonal Technology, Inc. (OMT) today announced its new human antibody platform using the first genetically engineered rats expressing a human antibody repertoire. The company, which also created the first targeted knockout rats in 2009, is now cross-breeding the knockout animals with the rats expressing human antibodies to finalize its platform.
It turns out that the rigid "line in the sand" over which the human sex chromosomes--the Y and X-- go to avoid crossing over is a bit blurrier than previously thought. Contrary to the current scientific consensus, Arizona State University assistant professor Melissa Wilson Sayres has led a research team that has shown that X and Y DNA swapping may occur much more often.
Women are significantly more likely than men to experience implant failure after primary total hip arthroplasty, suggests research published in JAMA Internal Medicine.
Biotectix, LLC announced today the acquisition of all significant assets owned by Chameleon BioSurfaces Ltd. (Cambridge, United Kingdom). Financial terms were not disclosed.
› Verified 3 days ago
| Entity Name | Allergy Asthma Care P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265440390 PECOS PAC ID: 5698779080 Enrollment ID: O20060825000279 |
News Archive
Open Monoclonal Technology, Inc. (OMT) today announced its new human antibody platform using the first genetically engineered rats expressing a human antibody repertoire. The company, which also created the first targeted knockout rats in 2009, is now cross-breeding the knockout animals with the rats expressing human antibodies to finalize its platform.
It turns out that the rigid "line in the sand" over which the human sex chromosomes--the Y and X-- go to avoid crossing over is a bit blurrier than previously thought. Contrary to the current scientific consensus, Arizona State University assistant professor Melissa Wilson Sayres has led a research team that has shown that X and Y DNA swapping may occur much more often.
Women are significantly more likely than men to experience implant failure after primary total hip arthroplasty, suggests research published in JAMA Internal Medicine.
Biotectix, LLC announced today the acquisition of all significant assets owned by Chameleon BioSurfaces Ltd. (Cambridge, United Kingdom). Financial terms were not disclosed.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Rigg, MD 5521 W Lincoln Hwy Ste 100, Crown Point, IN 46307-1098 Ph: (219) 756-6100 | Lauren Rigg, MD 5521 W Lincoln Hwy Ste 100, Crown Point, IN 46307-1098 Ph: (219) 756-6100 |
News Archive
Open Monoclonal Technology, Inc. (OMT) today announced its new human antibody platform using the first genetically engineered rats expressing a human antibody repertoire. The company, which also created the first targeted knockout rats in 2009, is now cross-breeding the knockout animals with the rats expressing human antibodies to finalize its platform.
It turns out that the rigid "line in the sand" over which the human sex chromosomes--the Y and X-- go to avoid crossing over is a bit blurrier than previously thought. Contrary to the current scientific consensus, Arizona State University assistant professor Melissa Wilson Sayres has led a research team that has shown that X and Y DNA swapping may occur much more often.
Women are significantly more likely than men to experience implant failure after primary total hip arthroplasty, suggests research published in JAMA Internal Medicine.
Biotectix, LLC announced today the acquisition of all significant assets owned by Chameleon BioSurfaces Ltd. (Cambridge, United Kingdom). Financial terms were not disclosed.
› Verified 3 days ago